Cite
Discovery and pharmacological characterization of AZD3229, a potent KIT/PDGFRα inhibitor for treatment of gastrointestinal stromal tumors
MLA
Ross Overman, et al. “Discovery and Pharmacological Characterization of AZD3229, a Potent KIT/PDGFRα Inhibitor for Treatment of Gastrointestinal Stromal Tumors.” Science Translational Medicine, vol. 12, no. 541, Aug. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6fcdee9e22eb865b4d98090dd3ef4933&authtype=sso&custid=ns315887.
APA
Ross Overman, Evan Barry, Sylvie Guichard, Crystal Brown, Oladipupo Adeyemi, Deborah Lawson, Rhys D.O. Jones, Venkatesh Pilla Reddy, Sabina Cosulich, Jerome T. Mettetal, Haiyun Wang, Teresa Collins, Martin J. Packer, Erica Banks, Stephen Fawell, Lisa Drew, Alexander R. Harmer, Deepa Bhavsar, David Wilson, … Rana Anjum. (2019). Discovery and pharmacological characterization of AZD3229, a potent KIT/PDGFRα inhibitor for treatment of gastrointestinal stromal tumors. Science Translational Medicine, 12(541).
Chicago
Ross Overman, Evan Barry, Sylvie Guichard, Crystal Brown, Oladipupo Adeyemi, Deborah Lawson, Rhys D.O. Jones, et al. 2019. “Discovery and Pharmacological Characterization of AZD3229, a Potent KIT/PDGFRα Inhibitor for Treatment of Gastrointestinal Stromal Tumors.” Science Translational Medicine 12 (541). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6fcdee9e22eb865b4d98090dd3ef4933&authtype=sso&custid=ns315887.